• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,568.50 -525.57
( -0.68%)
Global Indices
Nasdaq
51,748.06 162.36
(0.31%)
Dow Jones
7,496.17 -25.41
(-0.34%)
Hang Seng
72,454.13 1,204.07
(1.69%)
Nikkei 225
10,441.93 78.66
(0.76%)
Forex
USD-INR
94.32 -0.07
(-0.07%)
EUR-INR
108.15 -0.25
(-0.23%)
GBP-INR
124.70 -0.38
(-0.31%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
659.0470742
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
17.74
106967.27
EPS(TTM)
Face Value()
Div & Yield %
131.91
2
0.77
 

RailTel bags Rs 82-cr order from HRIDC
Jun 08,2026
The order involves the design, supply, installation, testing and commissioning (SITC) of signaling & telecommunication (S&T) and associated works for the Dhulawat–Manesar New Patli section, including Chandla, Dungerwas and Pachgaon Halt stations.

The project is scheduled to be completed by 27 November 2027.

RailTel Corporation of India was incorporated in 2000, with the objective of creating nationwide broadband and VPN services, telecom, and multimedia networks to modernize the train control operation and safety system of Indian Railways. The company’s standalone net profit jumped 35.7% to Rs 143.52 crore in Q4 FY26, compared with Rs 105.78 crore in Q4 FY25. Revenue from operations rose 27.6% YoY to Rs 1,668.86 crore in Q4 FY26.

Shares of RailTel Corporation of India fell 2.97% to close at Rs 303.55 on the BSE.